SPAP8B6.05c Antibody

Introduction to SPAP8B6.05c Antibody

The SPAP8B6.05c Antibody is a research-focused immunoglobulin targeting the SPAP8B6.05 gene product, which is implicated in chromosome-end fusion processes in Schizosaccharomyces pombe (fission yeast). This antibody is primarily referenced in genetic studies of subtelomeric regions, where it aids in investigating chromosomal structural integrity and genome stability .

Key Context from Literature:

• Gene Function: SPAP8B6.05 is located in the subtelomeric region of chromosome 2L and contributes to chromosome-end fusion during genome instability .

• Antibody Use: The antibody is used in molecular biology techniques such as chromatin immunoprecipitation (ChIP) and Western blotting to study subtelomeric protein localization and interactions .

Antibody Structure and Mechanism

Antibodies like SPAP8B6.05c follow the canonical Y-shaped structure of immunoglobulins, comprising two heavy chains and two light chains. Their function involves:

1. Antigen Binding: The Fab fragment recognizes specific epitopes on the SPAP8B6.05 protein.

2. Signal Transduction: The Fc region interacts with immune effector cells, enabling downstream processes like phagocytosis or complement activation .

Research Applications

The SPAP8B6.05c Antibody is utilized in:

1. Subtelomere Dynamics: Studying chromosome-end fusion events and genomic instability in S. pombe .

2. Protein Localization: Identifying interactions between SPAP8B6.05 and telomere-binding proteins via co-immunoprecipitation .

Supporting Data:

• Subtelomeric Fusion: SPAP8B6.05c is co-localized with telomeric proteins during fusion events (Figure 1 in ).

• ChIP-Seq Validation: The antibody demonstrates high specificity in pulldown assays, confirming SPAP8B6.05’s role in chromatin organization .

Limitations and Future Directions

• Limited Availability: The antibody is not commercially available and is restricted to niche research laboratories.

• Cross-Reactivity: Potential off-target binding to other subtelomeric proteins requires rigorous validation .